Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06779825 · ClinicalTrials.gov registry record
Impact of Stimulants and In-Scanner Motion on Attentive Task Performance in ADHD (ADHD_NFB)
A clinical trial, sponsored by Boston Children's Hospital.
- Not yet
- Registry status
- 30
- Enrollment target
NCT06779825 is a clinical trial that has not yet begun recruiting, run by Boston Children's Hospital. The registered enrollment target is 30 participants.
The verdict
NCT06779825 has not yet begun recruiting, sponsored by Boston Children's Hospital.
- NOT YET RECRUITING
- Registry status
- 30 participants
- Enrollment target
Study Summary
The goal of this interventional study is to learn the effects that stimulant medication prescribed to ADHD individuals has in their performance of attentive tasks, as measured by images and data collected through neuroimaging (fMRI) while also implementing new motion-correcting software. The main questions it aims to answer are: 1. How do the use of stimulants affect brain activity and motion in fMRI research in ADHD studies? 2. Can neurofeedback, an attentive task using real-time brain activity, engage the same brain circuits as seen with stimulant medication in individuals with ADHD? Researchers will compare participant's brain activity from the completion of attentive tasks performed in the scanner while following their regular medication regimen and while abstaining to take medication. Researchers will also compare how the data collected using a more precise motion correction software differs to other previously reported data from ADHD studies who possibly employed more lenient measures of motion correction. Participants will: 1. Be asked to complete at least 4 fMRI sessions, two of which will include neurofeedback 2. Be asked to abstain from taking stimulant medication on the day of two of these fMRI visits 3. Complete attentive tasks while in the scanner that will activate target brain regions of interest
Interventions
- COMBINATION_PRODUCT fMRI Neurofeedback attention task
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-02 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06779825
The ClinicalTrials.gov registry entry for NCT06779825 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fMRI Neurofeedback attention task is the first listed.
NCT06779825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06779825 about?
NCT06779825 is a clinical study titled "Impact of Stimulants and In-Scanner Motion on Attentive Task Performance in ADHD (ADHD_NFB)". The goal of this interventional study is to learn the effects that stimulant medication prescribed to ADHD individuals has in their performance of attentive tasks, as measured by images and data collected through neuroimaging (fMRI) while also implementing new motion-correcting software. The main qu...
What is the current status of trial NCT06779825?
This trial is currently not yet recruiting. The enrollment target is 30 participants. The study started on 2025-02. Estimated completion is 2026-12.
What interventions are being tested in trial NCT06779825?
The interventions under investigation include: fMRI Neurofeedback attention task (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06779825?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.